ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000246859.2	ABT-263 (navitoclax)	Colon adenocarcinoma	0.046322654	Resistant
ENSG00000246859.2	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.032925143	Sensitive